Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Ferric pyrophosphate (Primary) ; Ferric pyrophosphate
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 05 Apr 2018 According to a Rockwell Medical media release, data from the study will be presented at the National Kidney Foundation (NKF) Spring Clinical Meetings (2018).
- 28 Feb 2018 According to a Rockwell Medical India media release, data will be presented at the Annual Dialysis Conference 2018.
- 30 Oct 2017 According to a Rockwell Medical India media release, data from the study will be presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.